HP and gastric cancer: During a median follow‐up of 4.4 years (IQR: 2.9–5.9 years), metachronous GC occurred in 16 (6.9% [16/233], 16.3 cases/1000 person‐year) and 10 (15.4% [10/65], 37.5 cases/1000 person‐year) patients in the Hp‐negative and Hp‐positive groups, respectively.